Literature DB >> 22613651

Surgical treatment of cervicothoracic junction spinal tuberculosis via combined anterior and posterior approaches in children.

Xin-tao Wang1, Chang-long Zhou, Chun-yang Xi, Cheng-li Sun, Jing-long Yan.   

Abstract

BACKGROUND: Cervicothoracic junction spinal tuberculosis (CJST) in children is uncommon, especially when accompanied by a huge abscess. However, its consequences can be severe. Because of the special anatomic location of the cervicothoracic junction, surgical treatment is difficult and rarely reported. The aim of this clinical study was to assess the effectiveness of combined anterior and posterior approaches for focal debridement, decompression, allografting and anterior instrumentation in the treatment of CJST in children.
METHODS: Ten pediatric CJST patients underwent focal debridement and cord decompression through combined anterior and posterior approaches. Then an appropriate allograft and titanium plate were applied to reconstruct the spine. The patients were asked to wear head-neck-chest braces for six months and received regular anti-tubercular drugs therapy for 12 months.
RESULTS: The patients were followed-up for an average of 26 months (range, 15-32 months). There was no recurrent tuberculous infection. The bone grafts incorporated well and the instrumentation was stable. Cervical and thoracic kyphosis was successfully corrected from 40° (range, 30-52°) before the operation to 18° (range, 12-26°) post-operation. Neurological function was improved in all patients.
CONCLUSIONS: Combined anterior and posterior approaches for focal debridement, decompression, bone allografting and anterior instrumentation provided an effective means of treatment in children of CJST with a huge abscess in the posterior part of the vertebral body.

Entities:  

Mesh:

Year:  2012        PMID: 22613651

Source DB:  PubMed          Journal:  Chin Med J (Engl)        ISSN: 0366-6999            Impact factor:   2.628


  7 in total

1.  Surgical treatment approach of cervicothoracic junction spinal tuberculosis in pediatric: A case report.

Authors:  Muhammad Faris; Galih Indra Permana; Eko Agus Subagio; Abdul Hafid Bajamal
Journal:  Int J Surg Case Rep       Date:  2022-05-10

2.  Surgical approaches to upper thoracic Pott's disease with spinal instability during childhood: two cases.

Authors:  Gokhan Cavus; Yurdal Gezercan; Ali Ihsan Ökten; Orkun Tolunay; Tamer Çelik; Ali Arslan; Ümit Çelik
Journal:  Childs Nerv Syst       Date:  2017-12-16       Impact factor: 1.475

3.  Comparison of three surgical approaches for cervicothoracic spinal tuberculosis: a retrospective case-control study.

Authors:  Hao Zeng; Xiongjie Shen; Chengke Luo; Zhengquan Xu; Yupeng Zhang; Zheng Liu; Xiyang Wang
Journal:  J Orthop Surg Res       Date:  2015-07-02       Impact factor: 2.359

4.  Comparison of mid-term outcomes of posterior or postero-anterior approach using different bone grafting in children with lumbar tuberculosis.

Authors:  Hongqi Zhang; Qiang Guo; Shaohua Liu; Chaofeng Guo; Qile Gao; Mingxing Tang
Journal:  Medicine (Baltimore)       Date:  2019-03       Impact factor: 1.817

5.  Clinical Efficacy of Three Surgical Approaches for the Treatment of Cervicothoracic Tuberculosis: A Multicenter Retrospective Study.

Authors:  Wen-Jie Wu; Yong Tang; Jing-Tong Lyu; Sen Yang; Dong-Gui Wang; Qiang Zhang; Xun Liu; Jie-Zhong Deng; Fei Luo; Tian-Yong Hou; Jian-Zhong Xu; Ze-Hua Zhang
Journal:  Orthop Surg       Date:  2019-09-30       Impact factor: 2.071

6.  Surgical treatment of lumbosacral tuberculosis by one-stage debridement and anterior instrumentation with allograft through an extraperitoneal anterior approach.

Authors:  Jian-Hua Li; Ze-Hua Zhang; Tao Shi; Fei Dai; Qiang Zhou; Fei Luo; Tian-Yong Hou; Qing-Yi He; Mo-Yuan Deng; Jian-Zhong Xu
Journal:  J Orthop Surg Res       Date:  2015-05-10       Impact factor: 2.359

7.  Analysis and therapeutic schedule of the postoperative recurrence of bone tuberculosis.

Authors:  Lei Yang; Zhonghe Liu
Journal:  J Orthop Surg Res       Date:  2013-12-17       Impact factor: 2.359

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.